Song Ding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Song Ding has a total of 139 co-authors. Here are the top co-authors by number of shared publications:
- Jun Pu
State Key Laboratory for Oncogenes and Related Genes, Division of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China
10 shared publications Fei Liao
Department of Cardiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University; State Key Laboratory for Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai, China
5 shared publications- Jun Pu
Department of Cardiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
5 shared publications Zhinan Wu
Department of Cardiology, and Center Laboratory of Punan Branch, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
5 shared publicationsGuqing Luo
Department of Cardiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University; State Key Laboratory for Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai, China
4 shared publicationsJiyuan Chen
Department of Cardiology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University; State Key Laboratory for Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai, China
4 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Springer Nature in Nature Communications
ZEB1 maintains energy metabolism to sustain cardiac function through synergistic regulation with TEAD1
- 23 October 2026
- Published by Springer Nature in Nature Communications
Open AccessZEB1 maintains energy metabolism to sustain cardiac function through synergistic regulation with TEAD1
- Open Access
- 29 September 2026
- Published by Wiley in Advanced Science
- p. e78079
NCOA4 Accelerates Abdominal Aortic Aneurysm Formation by Regulating Macrophage Activation and Ferroptosis via STAT1–CH25H Axis
Abdominal aortic aneurysm (AAA) is a life‐threatening condition lacking effective pharmacological treatments, with emerging evidence highlighting the fundamental role of ferroptosis in its progression. Nuclear receptor coactivator 4 (NCOA4), known to mediate ferritinophagy and contribute to ferroptosis, is upregulated in macrophages from both angiotensin II (Ang II)‐induced murine AAA models and human AAA tissues. Global deletion of Ncoa4 in mice suppressed Ang II‐induced AAA formation. Combined approaches using bone marrow transplantation and macrophage‐specific adeno‐associated virus (AAV) confirmed that Ncoa4 knockdown in macrophages alleviates extracellular matrix (ECM) degeneration, inflammation, and vascular damage. Mechanistically, NCOA4 interacts with signal transducer and activator of transcription 1 (STAT1) to co‐activate the transcription of cholesterol 25‐hydroxylase (CH25H), an enzyme that catalyzes the production of 25‐hydroxycholesterol (25‐HC). Elevated 25‐HC levels were detected in the serum of both Ang II‐induced AAA mice and human AAA patients, and they promoted macrophage activation and ferroptosis, thereby driving AAA progression. Importantly, knockdown of Ch25h using lipid nanoparticle‐loaded microbubbles (LNP/MBs) attenuated macrophage ferroptosis and AAA progression. These findings reveal a critical role of the NCOA4/STAT1/CH25H axis in AAA pathogenesis and offer promising biomarkers and therapeutic strategies for the disease.
- 29 September 2026
- Published by Wiley in Advanced Science
- p. e78079
Open AccessNCOA4 Accelerates Abdominal Aortic Aneurysm Formation by Regulating Macrophage Activation and Ferroptosis via STAT1–CH25H Axis
Abdominal aortic aneurysm (AAA) is a life‐threatening condition lacking effective pharmacological treatments, with emerging evidence highlighting the fundamental role of ferroptosis in its progression. Nuclear receptor coactivator 4 (NCOA4), known to mediate ferritinophagy and contribute to ferroptosis, is upregulated in macrophages from both angiotensin II (Ang II)‐induced murine AAA models and human AAA tissues. Global deletion of Ncoa4 in mice suppressed Ang II‐induced AAA formation. Combined approaches using bone marrow transplantation and macrophage‐specific adeno‐associated virus (AAV) confirmed that Ncoa4 knockdown in macrophages alleviates extracellular matrix (ECM) degeneration, inflammation, and vascular damage. Mechanistically, NCOA4 interacts with signal transducer and activator of transcription 1 (STAT1) to co‐activate the transcription of cholesterol 25‐hydroxylase (CH25H), an enzyme that catalyzes the production of 25‐hydroxycholesterol (25‐HC). Elevated 25‐HC levels were detected in the serum of both Ang II‐induced AAA mice and human AAA patients, and they promoted macrophage activation and ferroptosis, thereby driving AAA progression. Importantly, knockdown of Ch25h using lipid nanoparticle‐loaded microbubbles (LNP/MBs) attenuated macrophage ferroptosis and AAA progression. These findings reveal a critical role of the NCOA4/STAT1/CH25H axis in AAA pathogenesis and offer promising biomarkers and therapeutic strategies for the disease.
- Open Access
- 1 August 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (11) , 2741-2752
Angiography-Derived Index of Microcirculatory Resistance Predicts Microvascular Obstruction and Infarct Size in Patients With STEMI
- 1 August 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (11) , 2741-2752
Open AccessAngiography-Derived Index of Microcirculatory Resistance Predicts Microvascular Obstruction and Infarct Size in Patients With STEMI
- Open Access
- 2 July 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (10) , 2515-2529
XGBoost Model With CMR Features for Prognostic Assessment in Patients With ST-Segment Elevation Myocardial Infarction
- 2 July 2026
- Published by Elsevier in JACC: Asia
- Vol. 6 (10) , 2515-2529
Open AccessXGBoost Model With CMR Features for Prognostic Assessment in Patients With ST-Segment Elevation Myocardial Infarction
- Open Access
- 29 July 2025
- Published by Elsevier in Materials Today Bio
- Vol. 34, 102152
Curcumin-loaded nanoscale coordination polymers for ROS scavenging and anti-inflammatory therapy in atherosclerosis
- 29 July 2025
- Published by Elsevier in Materials Today Bio
- Vol. 34, 102152
Open AccessCurcumin-loaded nanoscale coordination polymers for ROS scavenging and anti-inflammatory therapy in atherosclerosis
- Open Access
- 28 July 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (15) , 8246
Urolithin A Protects against Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Smooth Muscle Cell Pyroptosis via AMPK/NF-κB/NLRP3 Signaling
Recent studies confirmed that pyroptosis is involved in the progression of pulmonary hypertension (PH), which could promote pulmonary artery remodeling. Urolithin A (UA), an intestinal flora metabolite of ellagitannins (ETs) and ellagic acid (EA), has been proven to possess inhibitory effects on pyroptosis under various pathological conditions. However, its role on PH remained undetermined. To investigate the potential of UA in mitigating PH, mice were exposed to hypoxia (10% oxygen, 4 weeks) to induce PH, with or without UA treatment. Moreover, in vitro experiments were carried out to further uncover the underlying mechanisms. The in vivo treatment of UA suppressed the progression of PH via alleviating pulmonary remodeling. Pyroptosis-related genes were markedly upregulated in mice models of PH and reversed after the administration of UA. In accordance with that, UA treatment significantly inhibited hypoxia-induced pulmonary arterial smooth muscle cell (PASMC) pyroptosis via the AMPK/NF-κB/NLRP3 pathway. Our results revealed that UA treatment effectively mitigated PH progression through inhibiting PASMC pyroptosis, which represents an innovative therapeutic approach for PH.
- 28 July 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (15) , 8246
Open AccessUrolithin A Protects against Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Smooth Muscle Cell Pyroptosis via AMPK/NF-κB/NLRP3 Signaling
Recent studies confirmed that pyroptosis is involved in the progression of pulmonary hypertension (PH), which could promote pulmonary artery remodeling. Urolithin A (UA), an intestinal flora metabolite of ellagitannins (ETs) and ellagic acid (EA), has been proven to possess inhibitory effects on pyroptosis under various pathological conditions. However, its role on PH remained undetermined. To investigate the potential of UA in mitigating PH, mice were exposed to hypoxia (10% oxygen, 4 weeks) to induce PH, with or without UA treatment. Moreover, in vitro experiments were carried out to further uncover the underlying mechanisms. The in vivo treatment of UA suppressed the progression of PH via alleviating pulmonary remodeling. Pyroptosis-related genes were markedly upregulated in mice models of PH and reversed after the administration of UA. In accordance with that, UA treatment significantly inhibited hypoxia-induced pulmonary arterial smooth muscle cell (PASMC) pyroptosis via the AMPK/NF-κB/NLRP3 pathway. Our results revealed that UA treatment effectively mitigated PH progression through inhibiting PASMC pyroptosis, which represents an innovative therapeutic approach for PH.
- Open Access
- 1 February 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (2) , 196
Impact of Bivalirudin on Ischemia/Reperfusion Injury in Patients with Reperfused STEMI Assessed by Cardiac Magnetic Resonance
Thrombin is an important ischemia/reperfusion injury (IRI) mediator in patients with ST-elevation myocardial infarction (STEMI). This study examines the use of bivalirudin, a direct thrombin inhibitor, in reducing IRI in STEMI patients. STEMI patients (n = 21) were treated with bivalirudin and compared to 21 patients treated with unfractionated heparin (UFH) from the EARLY Assessment of Myocardial Tissue Characteristics by CMR in STEMI (EARLY-MYO-CMR) registry (NCT03768453). Infarct size (IS) and left ventricular ejection fraction (LVEF) were comparable between the two groups at follow up. During the first cardiac magnetic resonance (CMR) scan within the first week after percutaneous coronary intervention (PCI), all patients in both the bivalirudin and UFH groups exhibited myocardial edema. However, the myocardium edema volume was significantly less in the bivalirudin group (p < 0.05). At the one-month follow-up, a smaller proportion of patients in the bivalirudin group than in the UFH group exhibited myocardial edema (4.7% vs. 33.3%, p < 0.05). At the three-month follow-up, myocardial edema had completely resolved in the bivalirudin group, while it persisted in two patients in the UFH group. The incidence and volume of microvascular obstruction (MVO) were significantly lower in the bivalirudin group during the acute phase. Additionally, the incidence of intramyocardial hemorrhage (IMH) was significantly lower in the bivalirudin group during both the acute and follow up (p < 0.05). These findings were corroborated by T2 and T1 mapping results. The study concluded that the use of bivalirudin for anticoagulation is associated with attenuated IRI in STEMI patients who receive primary PCI.
- 1 February 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (2) , 196
Open AccessImpact of Bivalirudin on Ischemia/Reperfusion Injury in Patients with Reperfused STEMI Assessed by Cardiac Magnetic Resonance
Thrombin is an important ischemia/reperfusion injury (IRI) mediator in patients with ST-elevation myocardial infarction (STEMI). This study examines the use of bivalirudin, a direct thrombin inhibitor, in reducing IRI in STEMI patients. STEMI patients (n = 21) were treated with bivalirudin and compared to 21 patients treated with unfractionated heparin (UFH) from the EARLY Assessment of Myocardial Tissue Characteristics by CMR in STEMI (EARLY-MYO-CMR) registry (NCT03768453). Infarct size (IS) and left ventricular ejection fraction (LVEF) were comparable between the two groups at follow up. During the first cardiac magnetic resonance (CMR) scan within the first week after percutaneous coronary intervention (PCI), all patients in both the bivalirudin and UFH groups exhibited myocardial edema. However, the myocardium edema volume was significantly less in the bivalirudin group (p < 0.05). At the one-month follow-up, a smaller proportion of patients in the bivalirudin group than in the UFH group exhibited myocardial edema (4.7% vs. 33.3%, p < 0.05). At the three-month follow-up, myocardial edema had completely resolved in the bivalirudin group, while it persisted in two patients in the UFH group. The incidence and volume of microvascular obstruction (MVO) were significantly lower in the bivalirudin group during the acute phase. Additionally, the incidence of intramyocardial hemorrhage (IMH) was significantly lower in the bivalirudin group during both the acute and follow up (p < 0.05). These findings were corroborated by T2 and T1 mapping results. The study concluded that the use of bivalirudin for anticoagulation is associated with attenuated IRI in STEMI patients who receive primary PCI.
- Open Access
- 14 July 2023
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 24 (7) , 203
Impact of Glycemic Control on Coronary Inflammation Evaluated by Computed Tomography Pericoronary Fat Attenuation Index in Patients with Acute Coronary Syndrome
Background: Coronary inflammation causes significantly increased risk of cardiovascular disease (CVD) in diabetic patients. This study investigated the relationship between coronary local inflammation, detected by pericoronary fat attenuation index (FAI), and different blood glucose control levels in low-risk acute coronary syndrome (ACS) patients with or without diabetes. Methods: A total of 309 patients with low-risk ACS were classified into three groups: non-diabetes, well-regulated diabetes, and poorly regulated diabetes. Pericoronary FAI around the proximal or left anterior descending artery (LAD), left circumflex artery (LCX), and right coronary artery (RCA), were evaluated by coronary computed tomography angiography (CCTA), and systemic inflammatory variables and other biochemical indicators were detected by flow cytometry. Results: Pericoronary FAI values around the proximal LAD, LCX, and RCA in poorly regulated diabetes were significantly higher than those in well-regulated diabetes and non-diabetes, whereas those in well-regulated diabetes were not statistically different from those in non-diabetes. Further, plasma glycated hemoglobin (HbA1c) level was positively correlated with the pericoronary FAI values in LAD, LCX, and RCA. However, no significantly increased systemic inflammatory mediators were found in diabetic patients with poor glycemic control. Conclusions: Diabetic patients with poor glycemic control may have higher coronary local inflammation as detected by pericoronary FAI surrounding the three major coronary arteries. Clinical Trial Registration: NCT05590858.
- 14 July 2023
- Published by IMR Press in Reviews in Cardiovascular Medicine
- Vol. 24 (7) , 203
Open AccessImpact of Glycemic Control on Coronary Inflammation Evaluated by Computed Tomography Pericoronary Fat Attenuation Index in Patients with Acute Coronary Syndrome
Background: Coronary inflammation causes significantly increased risk of cardiovascular disease (CVD) in diabetic patients. This study investigated the relationship between coronary local inflammation, detected by pericoronary fat attenuation index (FAI), and different blood glucose control levels in low-risk acute coronary syndrome (ACS) patients with or without diabetes. Methods: A total of 309 patients with low-risk ACS were classified into three groups: non-diabetes, well-regulated diabetes, and poorly regulated diabetes. Pericoronary FAI around the proximal or left anterior descending artery (LAD), left circumflex artery (LCX), and right coronary artery (RCA), were evaluated by coronary computed tomography angiography (CCTA), and systemic inflammatory variables and other biochemical indicators were detected by flow cytometry. Results: Pericoronary FAI values around the proximal LAD, LCX, and RCA in poorly regulated diabetes were significantly higher than those in well-regulated diabetes and non-diabetes, whereas those in well-regulated diabetes were not statistically different from those in non-diabetes. Further, plasma glycated hemoglobin (HbA1c) level was positively correlated with the pericoronary FAI values in LAD, LCX, and RCA. However, no significantly increased systemic inflammatory mediators were found in diabetic patients with poor glycemic control. Conclusions: Diabetic patients with poor glycemic control may have higher coronary local inflammation as detected by pericoronary FAI surrounding the three major coronary arteries. Clinical Trial Registration: NCT05590858.
- 16 June 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Medical Imaging
- Vol. 43 (1) , 51-63
Locating X-Ray Coronary Angiogram Keyframes via Long Short-Term Spatiotemporal Attention With Image-to-Patch Contrastive Learning
Locating the start, apex and end keyframes of moving contrast agents for keyframe counting in X-ray coronary angiography (XCA) is very important for the diagnosis and treatment of cardiovascular diseases. To locate these keyframes from the class-imbalanced and boundary-agnostic foreground vessel actions that overlap complex backgrounds, we propose long short-term spatiotemporal attention by integrating a convolutional long short-term memory (CLSTM) network into a multiscale Transformer to learn the segment-and sequence-level dependencies in the consecutive-frame-based deep features. Image-to-patch contrastive learning is further embedded between the CLSTM-based long-term spatiotemporal attention and Transformer-based short-term attention modules. The imagewise contrastive module reuses the long-term attention to contrast image-level foreground/background of XCA sequence, while patchwise contrastive projection selects the random patches of backgrounds as convolution kernels to project foreground/background frames into different latent spaces. A new XCA video dataset is collected to evaluate the proposed method. The experimental results show that the proposed method achieves a mAP (mean average precision) of 72.45% and a F-score of 0.8296, considerably outperforming the state-of-the-art methods. The source code and dataset are available at https://github.com/Binjie-Qin/STA-IPCon.
- 16 June 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Medical Imaging
- Vol. 43 (1) , 51-63
Locating X-Ray Coronary Angiogram Keyframes via Long Short-Term Spatiotemporal Attention With Image-to-Patch Contrastive Learning
Locating the start, apex and end keyframes of moving contrast agents for keyframe counting in X-ray coronary angiography (XCA) is very important for the diagnosis and treatment of cardiovascular diseases. To locate these keyframes from the class-imbalanced and boundary-agnostic foreground vessel actions that overlap complex backgrounds, we propose long short-term spatiotemporal attention by integrating a convolutional long short-term memory (CLSTM) network into a multiscale Transformer to learn the segment-and sequence-level dependencies in the consecutive-frame-based deep features. Image-to-patch contrastive learning is further embedded between the CLSTM-based long-term spatiotemporal attention and Transformer-based short-term attention modules. The imagewise contrastive module reuses the long-term attention to contrast image-level foreground/background of XCA sequence, while patchwise contrastive projection selects the random patches of backgrounds as convolution kernels to project foreground/background frames into different latent spaces. A new XCA video dataset is collected to evaluate the proposed method. The experimental results show that the proposed method achieves a mAP (mean average precision) of 72.45% and a F-score of 0.8296, considerably outperforming the state-of-the-art methods. The source code and dataset are available at https://github.com/Binjie-Qin/STA-IPCon.